Dicerna Pharmaceuticals Inc. (DRNA) Slipped -5.56% or -0.73 To Price $12.41 On Friday


Dicerna Pharmaceuticals Inc. (DRNA) slipped -5.56% or -0.73 to $12.41. It is near to 157350 shares traded, which is 22.95% compare to the average total volume 685541. The market cap of DRNA is $655.52 million. The year to date change is 34.83%. The 52 week price range is from $2.69 to $15.8. Price of DRNA have changed -7.01% during last week. It have changed 5.12% over last month, 22.35% over last 3 months, 56.06% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 13.49. It is 8.70% above current price. The 200-day Moving Averages for DRNA is 10.20. It is -17.81% below current price. The 52-week High is 15.8. It is 27.32% from the current price. The 52-week Low is 2.69. It is -78.32% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DRNA is 4.65 on 2018-06-15. Short % to float is 3.26%. There are some statistics of DRNA. It is has market cap $655.52 million. The share outstanding is 52.82 million. The average volume is 685541. The revenue is 726000. The percent of top 15 Institution holding is 85.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -139.38%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -113.61%.


Tags:

Share this post